Artesunate in the treatment of metastatic uveal melanoma - first experiences

被引:25
作者
Berger, TG
Dieckmann, D
Efferth, T
Schultz, ES
Funk, JO
Baur, A
Schuler, G
机构
[1] Heidelberg Univ, Ctr Mol Biol, Heidelberg, Germany
[2] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany
[3] Global Preclin R&D Merck KgaA, Darmstadt, Germany
[4] Univ Miami, Dept Microbiol & Immunol, Coral Gables, FL 33124 USA
关键词
artesunate; artemisinin; melanoma; uvea; Dacarbazine; Fotemustine; chemotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Artesunate (ART) is a derivative of artemisinin, the active principle of the Chinese herb Artemisia annua L. Artesunate is approved for the treatment of multidrug-resistant malaria and has an excellent safety profile. It has been shown that Artesunate, apart from its anti-malarial activity, has cytotoxic effects on a number of human cancer cell lines, including leukemia, colon cancer and melanoma. We report on the first long-term treatment of two cancer patients with ART in combination with standard chemotherapy. These patients with metastatic uveal melanoma were treated on a compassionate-use basis, after standard chemotherapy alone was ineffective in stopping tumor growth. The therapy-regimen was well tolerated with no additional side effects other than those caused by standard chemotherapy alone. One patient experienced a temporary response after the addition of ART to Fotemustine while the disease was progressing under therapy with Fotemustine alone. The second patient first experienced a stabilization of the disease after the addition of ART to Dacarbazine, followed by objective regressions of splenic and lung metastases. This patient is still alive 47 months after first diagnosis of stage IV uveal melanoma, a situation with a median survival of 2-5 months. Despite the small number of treated patients, ART might be a promising adjuvant drug for the treatment of melanoma and possibly other tumors in combination with standard chemotherapy. Its good tolerability and lack of serious side effects will facilitate prospective randomized trials in the near future.
引用
收藏
页码:1599 / 1603
页数:5
相关论文
共 50 条
[41]   A pilot study of sunitinib malate in patients with metastatic uveal melanoma [J].
Mahipal, Amit ;
Tijani, Lukman ;
Chan, Kathryn ;
Laudadio, MaryAnn ;
Mastrangelo, Michael J. ;
Sato, Takami .
MELANOMA RESEARCH, 2012, 22 (06) :440-446
[42]   Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma [J].
Modi, Sachin ;
Gibson, Tom ;
Vigneswaran, Ganesh ;
Patel, Shian ;
Wheater, Matthew ;
Karydis, Ioannis ;
Gupta, Sanjay ;
Takhar, Arjun ;
Pearce, Neil ;
Ottensmeier, Christian ;
Stedman, Brian .
MELANOMA RESEARCH, 2022, 32 (02) :103-111
[43]   Clinical Course of a Presumed Metastatic Uveal Melanoma to the Contralateral Choroid [J].
Caminal Mitjana, Josep M. ;
Vila Grane, Natalia ;
Adan Civera, Alfredo ;
Sabater, Noelia ;
Arias Barquet, Lluis ;
Rubio Caso, Marcos J. .
SEMINARS IN OPHTHALMOLOGY, 2015, 30 (5-6) :417-419
[44]   The safety of nivolumab for the treatment of metastatic melanoma [J].
O'Reilly, Aine ;
Larkin, James .
EXPERT OPINION ON DRUG SAFETY, 2017, 16 (08) :955-961
[45]   Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma [J].
Ott, Patrick A. ;
Chang, Jason L. ;
Oratz, Ruth ;
Jones, Amanda ;
Farrell, Kathleen ;
Muggia, Franco ;
Pavlick, Anna C. .
CHEMOTHERAPY, 2009, 55 (04) :221-227
[46]   Treatment of liver metastases from uveal melanoma [J].
Rivoire, M ;
Kodjikian, L ;
Baldo, S ;
Kaemmerlen, P ;
Négrier, S ;
Grange, JD .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (06) :422-428
[47]   Time to treatment of uveal melanoma in the United Kingdom [J].
Bertil Damato .
Eye, 2001, 15 :155-158
[48]   Time to treatment of uveal melanoma in the United Kingdom [J].
Damato, B .
EYE, 2001, 15 (2) :155-158
[49]   The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway an Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells [J].
Zheng, Lei ;
Pan, Jingxuan .
CURRENT CANCER DRUG TARGETS, 2018, 18 (10) :988-998
[50]   Treatment of Liver Metastases From Uveal Melanoma [J].
Michel Rivoire ;
Laurent Kodjikian ;
Stefano Baldo ;
Pierre Kaemmerlen ;
Sylvie Négrier ;
Jean-Dominique Grange .
Annals of Surgical Oncology, 2005, 12 :422-428